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Daughters of diabetes patients have lower insulin sensitivity than women with no diabetes family history, but increase insulin sensitivity
to a greater extent with exercise training. This study aimed to determine whether differences in circulating concentrations of adiponectin and
leptin, and adipose tissue expression of their genes and receptors played a role. Women offspring of patients with type 2 diabetes mellitus
(n = 34; age, 35.6 ± 7.0 years; body mass index, 28.1 ± 5.1 kg/m2) and matched controls with no diabetes family history (n = 36; age, 33.6 ±
6.1 years; body mass index, 27.3 ± 4.7 kg/m2) participated. Blood and abdominal subcutaneous adipose tissue samples were obtained at
baseline and after a controlled 7-week endurance-type exercise intervention (sessions were performed at 65%-80% of maximum heart rate).
At baseline, no significant differences were observed between groups in circulating leptin or adiponectin concentrations, or expression of
their genes or receptors. In response to exercise, plasma leptin decreased more in offspring than controls (−32.2% vs −7.3%, P = .005 for
interaction); and the long isoform of the leptin receptor messenger RNA (mRNA) increased significantly only in the offspring (+39.4%, P =
.026 vs +7.7%, P = .892). Leptin mRNA decreased similarly in both groups (−24.7% vs −25.0%, P b .05 for both). Furthermore, changes in
plasma leptin (r = −0.432, P b .001) and leptin mRNA (r = −0.298, P = .019) correlated significantly with changes in insulin sensitivity.
Plasma adiponectin decreased similarly in both groups (−12.1% vs −15.2%, P b .01 for both), but no significant changes were observed in
adiponectin-related gene expression. This work shows that exercise training has differing effects on leptin-related variables between women
with and without a diabetes family history and suggests that these molecular differences may contribute to the differential effects of exercise
training on insulin sensitivity between these 2 groups.
© 2011 Elsevier Inc. All rights reserved.1. Introduction
The central role of obesity in insulin resistance and type 2
diabetes mellitus suggests an important role for adipose
tissue in the development of these conditions. Although liver
and skeletal muscle are the central tissues determining
“whole-body” insulin sensitivity [1], it is becoming clear that
adipose tissue–derived factors have important effects onInstitutional approval: The trial was approved by the Research Ethics
Committee of the North Glasgow University Hospitals NHS Trust and was
registered with ClinicalTrials.gov (Trial identifier: NCT00268541).
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doi:10.1016/j.metabol.2009.12.026insulin/glucose metabolism in these organs. Originally, the
function of adipose tissue was thought to be as the site of
energy storage; however, it has become clear that adipose
tissue is in fact the largest endocrine organ in the body,
secreting many bioactive substances (adipokines) that are
required for normal body function and are found at altered
levels in metabolic disease [2]. Two of these, adiponectin [3]
and leptin [4], are implicated in insulin resistance and may
play a role in the etiology of diabetes.
Offspring of diabetic patients have approximately 3 times
the risk of developing diabetes vs those with no family history
of diabetes [5,6]; and when matched for body mass index
(BMI), they are often still more insulin resistant than control
subjects [7-9]. Differences in adipokine concentrations
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to have lower circulating adiponectin [10,11] and higher
circulating leptin concentrations [12] than matched controls.
Although this may be due partly to differences in adipose
tissue mass and distribution, differences in the functionality
of adipose tissue, in terms of protein production and gene
expression per unit mass of adipose tissue, and in the tissue
response to altered environments, such as exercise, are also
likely to play a role.
Exercise training is an intervention that improves insulin
sensitivity. We have recently demonstrated that 7 weeks of
moderate-intensity exercise training induced a 3-fold greater
improvement in insulin sensitivity in offspring than matched
control subjects [13]. Circulating leptin concentrations
decreased significantly only in the offspring in response to
the intervention and the change correlated significantly with
the change in insulin sensitivity, independently of change in
body mass [13], suggesting that this change in insulin
sensitivity may be mediated through leptin. However, the
effect of exercise on circulating adiponectin remains
inconclusive, with increases [14,15], decreases [16] and
“no change” [17] reported in different studies. Similarly, the
effects of exercise training on adipose tissue gene expression
of leptin, adiponectin, and their receptors, which would
indicate sensitivity to these adipokines, are not known. These
data would help to provide a more complete understanding
of the mechanisms by which exercise training modulates
adiponectin and leptin, and why differential effects are
observed in offspring and controls; these would also allow an
investigation of the interactions between adipokines, their
receptors, and environmental stimuli in different population
groups, which may help explain these differential effects.
The purpose of the present study was therefore to determine
whether the above factors differed between sedentary offspring
and control subjects, whether they correlated with the observed
differences in insulin sensitivity, and whether changes in these
factors or relationships with insulin sensitivity after exercise
training differed between groups.2. Methods
The participants and study design have previously been
described in detail [13]. Briefly, 34 women with at least one
parent with type 2 diabetes mellitus (offspring; age, 35.6 ±
7.0 years; BMI, 28.1 ± 5.1 kg/m2) and 36 women with no
first- or second-degree relative with type 2 diabetes mellitus,
matched for age and BMI with the offspring (control; age,
33.6 ± 6.1 years; BMI, 27.3 ± 4.7 kg/m2), participated. All
subjects were sedentary, healthy, normoglycemic, nonsmo-
kers with a regular menstrual cycle and gave written
informed consent. Because of dropouts, postintervention
data are for 28 offspring and 34 controls. No significant
differences at baseline were observed between those who
dropped out and those who completed the study (data not
shown). The trial was approved by the Research EthicsCommittee of the North Glasgow University Hospitals NHS
Trust and was registered with ClinicalTrials.gov (Trial
identifier: NCT00268541). Subjects underwent adipose
tissue biopsy and an oral glucose tolerance test at baseline
and after a progressive 7-week endurance-type exercise
training program that is described in detail in Barwell et al
[13]. Briefly, exercise sessions were performed at 65% to
80% of maximum heart rate beginning with 3 exercise
sessions of 30 minutes in week 1 and building to 5 exercise
sessions of 60 minutes in weeks 6 and 7. Postexercise
testing, including the biopsy, was done between 15 and 24
hours after the final training session. Subjects were asked not
to alter their dietary habits during their participation in the
study and completed 7-day weighed food diaries before each
metabolic testing day that were analyzed using a comput-
erized version of the food composition tables (CompEat Pro;
Nutrition Systems, Banbury, United Kingdom).
Body composition and fat distribution measurements were
made using dual x-ray absorptiometry scans (LUNAR Prodigy
DEXA scanner; GE Healthcare Diagnostic Imaging, Slough,
United Kingdom). Blood samples were collected into potassi-
um EDTA on ice, separated within 15 minutes, and stored at
−80°C. Adiponectin and leptin concentrations were determined
in fasted state blood samples using enzyme-linked immuno-
sorbent assay kits (R&D Systems Europe, Abingdon, United
Kingdom). Insulin and glucose were determined in blood
samples collected in the fasted state and 30, 60, 90, and 120
minutes after oral glucose tolerance test glucose ingestion by
enzyme-linked immunosorbent assay (Mercodia, Uppsala,
Sweden) and enzymatic colorimetric reaction (Roche, Welwyn
Garden City, United Kingdom) kits, respectively. Within-assay
coefficients of variation were 3.9%, 8.0%, 3.9% and 0.8%,
respectively. Insulin sensitivity was calculated using the insulin
sensitivity index (ISI) [18], which is highly correlated with the
rate of whole-body glucose disposal during a euglyemic-
hyperinsulinemic clamp [18].
Subcutaneous abdominal adipose tissue biopsies (∼300
mg) were taken with a needle at the level of the umbilicus
and had blood and any nonadipose tissue contamination
removed with sterile forceps and washing with 0.9% saline
solution on a gauze. Each biopsy was split into 2 similarly
sized pieces (∼150 mg) before flash-freezing in liquid
nitrogen, all within 2 minutes of collection. Total RNA was
extracted from one of these pieces using the RNeasy Lipid
Tissue Mini Kit (Qiagen, Crawley, United Kingdom)
according to the manufacturer's protocol with mechanical
homogenization in a RiboLyser (Thermo Scientific, Lough-
borough, United Kingdom). Complementary DNA was
synthesized using the Reverse-iT MAX 1st Strand Synthesis
Kit (ABGene, Epsom, United Kingdom) with random
hexamers, 500 ng of RNA, and twice the recommended
volume of all ingredients, but otherwise according to the
manufacturer's protocol. After stopping, reactions were
diluted from 40 to 250 μL with distilled water.
Quantitative polymerase chain reaction (PCR) assays
were designed for each transcript (Supplementary Table A)
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(http://www.roche-applied-science.com/). Messenger RNA
(mRNA) expression levels of transcripts were measured in
triplicate using the Universal ProbeLibrary Set (Roche) and
ABsolute QPCR Mix (ABGene). Each reaction contained
1.35 μL of each primer (10 μmol/L stock), 0.15 μL probe,
and 1 μL complementary DNA in a final volume of 15 μL.
Cycle threshold (Ct) outliers were removed using the
median absolute deviation method (0.6745 ⁎ absolute
difference of data point from median/median) with a
maximum acceptable threshold of 3.5. Average amplifica-
tion efficiency for each assay was determined using version
7.5 of LinReg PCR [19], after exclusion of Ct outlier data
points and efficiency values lying greater than ±1.96
standard deviations (SDs) from the mean. Non–Ct-outliers
were averaged for each triplicate and corrected for
amplification efficiency (Ct ⁎ log [mean efficiency]/log
[2]). Each assay required reactions on multiple plates;
therefore, control samples were run on each plate with Ct
values on subsequent plates corrected to be directly compa-
rable to those on plate 1, using the formula Ct(on plate X) +
“average Ct control samples plate 1” − “average Ct control
samples plate X”.
Four potential calibrator genes (ACTB, GAPDH, RPLP0,
and LRP10) were compared for stability under experimental
conditions using NormFinder [20]. RPLP0 was found to be
the most stable across all subject groups and intervention
conditions. The corrected Ct values for each target gene and
RPLP0 were used to calculate the ΔCt, and the average ΔCt
of the baseline control group was used to calculate theΔΔCt.
The relative expression values used for statistical analyses
and quoted in Table 1 were given by 2−ΔΔCt.
Data were analyzed using Statistica (version 6.0; StatSoft,
Tulsa, OK), Minitab (version 13.1; Minitab, State College,
PA), and R (version 2.7.2 [21]; R Foundation for Statistical
Computing, Vienna, Austria). Data were tested for normality
using the Kolmogorov-Smirnov normality test: plasma
adiponectin and leptin were log transformed. Gene expres-
sion data were relative and therefore log transformed to
ensure normality of errors.Table 1
Concentrations of plasma adipokines and gene expression at baseline
Control (n = 36)
ISI 6.35 (5.27-7.65)
Fat mass (kg) 27.3 (24.3-30.6)
Plasma adiponectin (mg/mL) 6.88 (6.04-7.85)
Plasma leptin (pg/mL) 14.9 (12.1-18.2)
ADIPOQ 1.00 (0.87-1.14)
ADIPOR1 1.00 (0.87-1.15)
ADIPOR2 1.00 (0.93-1.08)
LEPTIN 1.00 (0.83-1.21)
LEPR (long isoform) 1.00 (0.82-1.21)
LEPR (short isoforms) 1.00 (0.85-1.17)
Statistical analyses were performed on log-transformed data. Values are means and
values are relative to RPLP0 expression and the average target to RPLP0 ratio of
leptin have been reported previously [12], but are included here to allow full analBaseline differences between groups were determined
using unpaired t tests. Effects of exercise on the 2 groups
were assessed by 2-way analysis of variance with repeated
measures and post hoc Tukey tests. Associations between
variables were assessed using Pearson correlations.
Adipokine systems were defined as plasma concentration
of each adipokine plus subcutaneous adipocyte mRNA
expression levels of the adipokine and its receptor genes
(Supplementary Table A). Stepwise regression analyses in R
identified the best multivariate model to explain the observed
data both before (baseline) and in response to (Δ) the
exercise intervention. Initial models included all variables
plus all possible 2-way interactions. Fat mass correlated well
with ISI in both groups at baseline (Table 2) and was
therefore included in the modeling to understand if the
adipokine “systems” had effects over and above fat mass and
if any influence of either “system” was dependent on fat
mass. Before modeling, quantitative data were z scored; that
is, values for each phenotype were expressed as number of
SDs they were away from the mean value for that phenotype.
Therefore, the hypothetical average individual would have a
baseline score of 0. Similarly, an individual with no change
in response to exercise would have a Δ z score of 0.
Individuals in the control group were assigned a group value
of 0, whereas offspring were assigned a group value of 1.
The formulae in Tables 4 and 5 and Supplementary Tables C
and D can be interpreted in light of this. The “drop1” and
“add1” functions of the “stats” package were used alternately
until all terms that remained in the model were either
significant (P ≤ .05) or required in the model because of a
significant higher-order term. Inclusion of 2-way interactions
allowed investigation of whether the influence of certain
variables required knowledge of other variables. In biolog-
ical terms, this allowed us to ask, for example, if the effect of
plasma leptin was dependent on the levels of leptin receptor
expression. Retrospective calculations of achieved power
using G⁎power (v3.0.10; Franz Faul, Universität Kiel,
Germany), the full model (ie, the maximum number of
predictors), and the achieved adjusted R2 values showed that
for adiponectin, leptin, and combined baselines modeling weOffspring (n = 34) P value (unpaired t test)
4.75 (3.85-5.86) .047
29.6 (26.1-33.5) .359
6.58 (5.65-7.67) .663
17.5 (13.5-22.6) .329
0.92 (0.75-1.13) .489
1.03 (0.90-1.18) .783
0.97 (0.88-1.06) .591
0.97 (0.76-1.23) .837
0.99 (0.79-1.25) .966
1.03 (0.85-1.25) .813
95% confidence limits back transformed to original units. Gene expression
the control group at baseline. Insulin sensitivity index, fat mass, and plasma
yses of combined results.
Table 2
Correlations between ISI at baseline with other baseline variables (baseline) and between change in ISI and changes in other variables in response to the exercise
intervention (Δ)
Plasma adipokine (gene) Combined group Control group Offspring group
Baseline (N = 70a) Δ (n = 62a) Baseline (n = 36a) Δ (n = 34a) Baseline (n = 34a) Δ (n = 28a)
Subject group r = −0.239
P = .047
r = 0.268
P = .035
Fat mass r = −0.540
P b .001
r = −0.152
P = .265
r = −0.396
P = .023
r = 0.181
P = .337
r = −0.653
P = b .001
r = −0.454
P = .020
Plasma adiponectin r = 0.452
P b .001
r = 0.068
P = .598
r = 0.384
P = .021
r = 0.055
P = .757
r = 0.512
P = .002
r = 0.037
P = .852
ADIPOQ mRNA r = 0.203
P = .093
r = −0.021
P = .870
r = 0.062
P = .720
r = −0.015
P = .932
r = 0.275
P = .116
r = −0.066
P = .739
ADIPOR1 mRNA r = 0.129
P = .288
r = 0.035
P = .790
r = 0.084
P = .625
r = −0.094
P = .598
r = 0.200
P = .256
r = 0.090
P = .648
ADIPOR2 mRNA r = 0.137
P = .257
r = −0.051
P = .696
r = −0.034
P = .846
r = −0.155
P = .382
r = 0.256
P = .144
r = 0.048
P = .808
Plasma leptin r = −0.550
P b .001
r = −0.432
P b .001
r = −0.574
P b .001
r = −0.351
P = .042
r = −0.516
P b .001
r = −0.396
P = .037
Leptin mRNA r = −0.217
P = .071
r = −0.298
P = .019
r = −0.360
P = .031
r = −0.297
P = .089
r = −0.127
P = .475
r = −0.345
P = .072
Leptin receptor (long) mRNA r = 0.072
P = .552
r = 0.203
P = .113
r = 0.063
P = .715
r = 0.179
P = .311
r = 0.082
P = .646
r = 0.136
P = .490
Leptin receptor (short) mRNA r = −0.047
P = .702
r = 0.105
P = .418
r = −0.184
P = .282
r = 0.232
P = .187
r = 0.077
P = .665
r = −0.041
P = .836
a N values for fat mass were 65 and 56, respectively (combined group); 33 and 30, respectively (control group); and 32 and 26, respectively (offspring group).
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effects of the demonstrated size. For modeling of adiponectin
and leptinΔs, we had 52.0% and 98.6% power, respectively.
Although the power to detect a true effect of adiponectin of
the observed size is much lower than we would like, the
reduced model produced by the stepwise regression
modeling for adiponectin achieved 86.2% power.3. Results
Insulin sensitivity, fat mass, and plasma leptin data have
been reported previously [13] but are included in tables to
allow interpretation of the gene expression data and
circulating adiponectin data in context and consideration of
each adipokine “system” as a whole. Further descriptive data
about the study participants are also available in that
publication [13].
Table 1 describes the baseline data. No significant
differences were observed in concentrations of circulating
adipokines or in gene expression levels. For all subjects
together, ISI correlated positively with circulating adipo-
nectin and negatively with circulating leptin (Fig. 1),
explaining 20.4% and 30.3% of the variance, respectively.
These relationships with ISI were also evident in the separate
offspring and control groups (Table 2). Leptin mRNA levels
correlated significantly with ISI in the control group but not
the offspring group (Table 2).
Changes in variables in response to the exercise
intervention are shown in Table 3. In all subjects combined,
plasma adiponectin and leptin were significantly reduced byexercise; however, separate consideration of the groups
shows that the reduction in leptin was significant only in the
offspring group, whereas adiponectin was significantly
reduced in both groups. Leptin gene expression was
significantly reduced by exercise overall and in separate
groups, whereas the long isoform of the leptin receptor
(LEPRlong) gene expression was significantly increased
overall; but when the groups were considered separately, the
increase was only significant in the offspring group.
Exercise-induced changes in plasma leptin and leptin gene
expression (Fig. 1 and Table 2) correlated with the change in
ISI in the combined group, explaining 18.7% and 8.9% of
the variance, respectively. Similar correlations were found in
each of the subgroups, although they did not reach
significance for leptin mRNA in these smaller subgroups.
Correlations between the variables and fat mass are shown in
Supplementary Table B for information, although the
findings of this study were not substantially altered by
expressing ISI per unit fat mass (data not shown).
At baseline, stepwise regression modeling showed that
variation in the leptin “system” could account for 48.6% of
the variance in ISI (Table 4). Those in the offspring group
had 0.339 SD lower ISI than controls if they had average (ie,
0) values of all other data. More complex terms in the model
require evaluation of several variables at once. Control
individuals with 1 SD higher than average fat mass had a
relatively average ISI (+0.089 SD), whereas offspring
individuals had 1.193 SD lower (+0.089 − 1.282) than
average ISI. Control individuals with 1 SD higher than
average plasma leptin had 0.568 SD lower than average ISI,
whereas offspring individuals had a 0.573 SD higher
Fig. 1. Correlations between ISI and plasma adipokine or adipocyte mRNA levels at baseline (baseline) and between change in ISI and changes in plasma
adipokine or adipocyte mRNA levels (Δ). Black triangles (▲) represent the offspring group, whereas open squares (□) represent the control group. Regression
line (central line) and 95% confidence limits (outer lines) are shown.
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higher short isoform of the leptin receptor (LEPRshort)
mRNA expression level, these values would be reduced by
0.514 SD (−0.179 − 0.335). Individuals with a 1 SD higher
than average leptin mRNA expression level would have
0.124 SD lower than average ISI. If they also had 1 SD
higher than average LEPRshort mRNA expression level,
then they would have 0.031 SD lower (−0.124 − 0.179 +
0.272) than average ISI. Those with 1 SD higher than
average LEPRlong mRNA expression level had 0.322 SD
higher than average ISI.
Baseline variation in the adiponectin “system” accounted
for 48.0% of the variance in ISI (Table 4) with individual
components quantifiable as above. A similar approach,explaining 72.4% of the ISI variance, can be used to identify
important interactions between the adiponectin and leptin
“systems.” The influence of ADIPOQ, ADIPOR1, and
ADIPOR2 mRNAs were all dependent on subject group, as
ADIPOQ and ADIPOR1 mRNAs were for the adiponectin
“system” alone. Significant points of interaction between the
“systems” were as follows—(1) Plasma adiponectin and
LEPRlong mRNA: If 1 SD higher than average for both, ISI
was 0.332 SD lower for the offspring group, although it was
relatively unchanged (+0.054) in the control group. (2)
Plasma leptin and ADIPOR1 mRNA: If 1 SD higher than
average for both, ISI was 1.480 SD higher for the control
group, although it was relatively unchanged (+0.089) in the
offspring group. (3) Leptin mRNA and ADIPOR1 mRNA: If
Table 3
Exercise induced changes (percentage) in ISI, fat mass, plasma adipokines, and gene expression
Combined group (n = 62) Pa Control group (n = 34) Pb Offspring group (n = 28) Pc Pd
ISI 16.7 (7.1 to 27.2) b.001 7.3 (−3.0 to 18.7) .613 29.2 (12.4 to 48.5) .001 .035
Fat mass −15.2 (−20.5 to −9.6) b.001 −12.1 (−18.7 to −4.8) .022 −13.8 (−18 to −9.4) .004 .556
Plasma adiponectin −13.8 (−18.0 to −9.4) b.001 −15.2 (−20.5 to −9.6) b.001 −12.1 (−18.7 to −4.8) .007 .477
Plasma leptin −19.5 (−28.0 to −10.0) b.001 −7.3 (−19.1 to 6.2) .725 −32.2 (−42.5 to −20.1) b.001 .005
ADIPOQ mRNA −4.6 (−12.3 to 3.9) .314 −6.8 (−16.1 to 3.6) .633 −1.8 (−14.6 to 12.8) .992 .558
ADIPOR1 mRNA 7.6 (−1.0 to 17.0) .083 5.4 (−3.9 to 15.5) .802 10.4 (−4.7 to 28.0) .408 .585
ADIPOR2 mRNA 0.6 (−5.8 to 7.5) .853 0.7 (−8.1 to 10.2) .999 0.6 (−8.8 to 11.0) .999 .998
Leptin mRNA −24.9 (−33.7 to −14.9) b.001 −25.0 (−37.7 to −9.7) .008 −24.7 (−36.1 to −11.3) .022 .975
LEPR (long isoform) mRNA 21.0 (3.8 to 41.0) .011 7.7 (−13.0 to 33.3) .892 39.4 (12.9 to 72.1) .026 .101
LEPR (short isoforms) mRNA 9.1 (−2.5 to 22.1) .102 1.7 (−9.3 to 14.1) .996 18.8 (−3.1 to 45.6) .186 .179
Statistical analyses were performed on log-transformed data. Values are means and 95% confidence limits. Insulin sensitivity index, fat mass, and plasma leptin
have been reported previously [12], but are included here to allow full analyses of combined results. Post hoc tests are Tukey honestly significant difference tests;
other P values are from repeated-measures analysis of variance.
a Exercise term.
b Post hoc exercise term for control group only.
c Post hoc exercise term for offspring group only.
d Interaction between subject group and exercise term.
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the control group and was further reduced to −2.252 in the
offspring group. (4) ADIPOR1 mRNA and LEPRlong
mRNA: If 1 SD higher than average for both, ISI was
slightly higher than average (+0.165) for the control group,
but was 1.206 SD lower than average for the offspring group.
(5) ADIPOR1 mRNA and LEPRshort mRNA: If 1 SD higher
than average for both, ISI was 0.849 SD higher than average
for the control group, although it lower than average (−0.522
SD) for the offspring group. (6) ADIPOR2 and leptin
mRNAs: If 1 SD higher than average for both, ISI was 0.760
SD lower than average for the control group, but 0.359 SD
higher than average for the offspring group.
Variation in the leptin “system”Δs accounted for 47.4% of
the variance in Δ ISI (Table 5). None of the changes in the
leptin “system” differed by group. The Δ fat mass was an
independent predictor of Δ ISI, although paradoxically a
reduction in fat mass was correlated with a reduction in ISI
(individuals who reduced their fat mass by 1 SD would haveTable 4
Final stepwise regression models for ISI and each adipokine “system” and the 2 “
Adipokine Model
Adiponectin ISI = + 0.156 − 0.294*(SG) − 0.593*FM + 0.285*pl.Adipo −
1.285*SG:AdipoQ − 1.126*SG:AdipoR1 + 0.621*SG:AdipoR
Leptin ISI = + 0.125 − 0.339*(SG) + 0.089*(FM) − 0.568*pl.Leptin
0.322*LEPRlong − 0.179*(LEPRshort) − 1.282*SG:FM + 1.1
0.335*pl.Leptin:LEPRshort + 0.272*Leptin mRNA:short
Combined ISI = + 0.370 − 0.278*(SG) − 0.490*FM + 0.292*pl.Adipo −
0.630*AdipoR2 + 0.012*(pl.Leptin) − 0.569*Leptin mRNA +
1.371*SG:AdipoR1 + 1.119*SG:AdipoR2 + 0.440*FM:Adipo
0.734*FM:Leptin mRNA + 0.524*pl.Adipo:AdipoQ − 0.448
0.793*AdipoR1:Leptin mRNA − 0.418*AdipoR1:LEPRlong
0.439*AdipoR2:Leptin mRNA − 0.443*pl.Leptin:Leptin mR
0.635* Leptin mRNA:LEPRlong − 0.310*pl.Adipo:AdipoR1
Terms in parentheses are nonsignificant but required in model for higher-order term
ADIPOQ, adiponectin mRNA; ADIPOR1, adiponectin receptor 1 mRNA; ADIPO
long form of the leptin receptor; LEPRshort, the short forms of the leptin receptorreduced their ISI by 1.405 SD if they changed nothing else).
Changes in plasma leptin and in LEPRlong mRNA were
nonsignificant as individual terms, although they were
required in the model for more complex terms. Individuals
who reduced their leptinmRNAby 1 SD increased their ISI by
0.289 SD. Individuals who reduced both their fat mass and
plasma leptin by 1 SD increased their ISI by 3.117 SD. Those
who reduced their plasma leptin and increased their expression
of LEPRlong mRNA increased their ISI by 0.326 SD.
Variation in the adiponectin “system” Δs accounted for
22.8% of the variance in Δ ISI (Table 5). Too few
individuals completed the study to reliably test for interac-
tions in the Δs of the 2 adipokine “systems.”4. Discussion
Our results demonstrate that, whereas there were no overt
baseline differences in plasma adiponectin, leptin, or relatedsystems” combined at baseline
0.762*AdipoQ + 0.495*AdipoR1 − 0.323*AdipoR2 +
2 + 0.205* AdipoQ:AdipoR2
P b .001
R adj
2 = 48.0%
− 0.124*(Leptin mRNA) +
41*SG:pl.Leptin −
P b .001
R adj
2 = 48.6%
0.039*(AdipoQ) + 0.481*AdipoR1 −
0.102*(LEPRlong) − 0.116*(LEPRshort) −
Q − 0.481*FM:AdipoR2 + 0.562*FM:pl.Leptin −
*pl.Adipo:LEPRlong + 0.987*AdipoR1:pl.Leptin −
+ 0.484*AdipoR1:LEPRshort +
NA − 0.799*pl.Leptin:LEPRlong +
+ 1.191*SG:AdipoQ
P b .001
R adj
2 = 72.4%
s. SG indicates subject group; FM, fat mass; pl.Adipo, plasma adiponectin;
R2, adiponectin receptor 2 mRNA; pl.Leptin, plasma leptin; LEPRlong, the
.
Table 5
Final stepwise regression models for change (Δ) in ISI and changes in each adipokine “system” and the 2 “systems” combined
Adipokine Model
Adiponectin ΔISI = + 0.155 − 0.039⁎(SG) − 1.465⁎ΔFM + 0.409⁎(Δpl.Adipo) + 0.059⁎(ΔADIPOR1) −
0.121⁎(ΔADIPOR2) − 1.028⁎SG:Δpl.Adipo − 3.504⁎ΔFM:Δpl.Adipo + 0.203⁎ΔADIPOR1:ΔADIPOR2
P = .008
R adj
2 = 22.8%
Leptin ΔISI = + 0.081 + 1.405⁎ΔFM − 0.081⁎(Δpl.Leptin) − 0.289⁎ΔLeptin mRNA + 0.001⁎(ΔLEPRlong) +
1.712⁎ΔFM:Δpl.Leptin − 0.244⁎Δpl.Leptin:ΔLEPRlong
P b .001
R adj
2 = 47.4%
Combined Too many possible terms relative to N value to test
Terms in parentheses are nonsignificant but required in model for higher-order terms.
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differences between women with and without a family
history of diabetes, plasma leptin and LEPRlong mRNA
only changed significantly in response to exercise training in
the offspring group, and exercise-induced changes in the
“leptin system” could explain almost half the exercise-
induced change in ISI. Furthermore, whereas adiponectin-
related variables did not change differently between the
groups in response to exercise training, changes in the
“adiponectin system” explained almost a quarter of the
variance of the change in ISI. The modeling approach used in
the present study enabled the elucidation of complex
relationships that were not immediately obvious and showed
that the adipokine correlations were both over and above,
and dependent on, fat mass. This also highlighted relation-
ships between the adipokine “systems” and ISI that differed
by subject group at baseline and showed that the effects of
subject group on ISI response to exercise may be mediated
through changes to leptin variables.
Baseline circulating leptin values were similar to those
reported in the literature for similar subject groups [22].
Although there were no group differences at baseline in
circulating leptin concentration or expression of the leptin
gene or its receptors, subject group was an important element
of the leptin “system” modeling of ISI. The final model,
which explains almost half of the variance in ISI, indicates
that fat mass is more important in determining ISI in the
offspring than the control group and that increased plasma
leptin is correlated with reduced ISI in the control group, but
increased ISI in the offspring group. One interpretation of
this is that, after accounting for other variables, the role of
plasma leptin, or the context in which it works in the 2
groups, is different. The notion of differing roles for leptin in
different contexts is consistent with the ideas of Magni et al
[23] who showed that free and bound leptin correlates with
different aspects of biology: fat mass and resting energy
expenditure, respectively. The influence of plasma leptin on
ISI was also determined by the expression level of
LEPRshort mRNA, as was the influence of leptin mRNA.
The function of these short transcripts is unknown, although
they are thought to play a role in clearance of leptin from the
circulation [24], which would alter the availability of plasma
leptin, and in transport of leptin across the blood-brain
barrier [25], which would alter the site of action of leptin.
Increased expression of LEPRlong mRNA correlated with
increased ISI regardless of group as would have beenpredicted because the full-length leptin receptor is required
for leptin signaling [26]. Interestingly, expression of LEPR-
long only increased significantly in response to training in
the offspring group—an effect that would increase adipose
tissue sensitivity to a given level of plasma leptin.
Modeling of the change in ISI against the change in the
leptin “system” explained 47.7% of the variance in the
change in ISI but did not identify subject group as an
important element. This is likely due to the difference
between the groups in the change in plasma leptin and the
change in LEPRlong mRNA, such that the “group
information” is contained in the Δ values of these variables.
The final model shows that the influence of fat mass cannot
be interpreted without appreciating the concurrent change in
plasma leptin. Both on average reduce, as does leptin
mRNA, all resulting in an increase in ISI. Similarly, the
effect of the change in plasma leptin cannot be interpreted
without appreciating the change in the expression of
LEPRlong mRNA, which is required for plasma leptin to
elicit a signal [26]. On average, plasma leptin reduced with
exercise and LEPRlong increased. The model predicts that
this would result in an increase in ISI, perhaps through the
predicted resulting increase in leptin signaling.
Baseline circulating adiponectin values were similar to
those reported in the literature for similar subject groups
[22]. In cross-sectional studies, high circulating adiponectin
concentrations are associated with high insulin sensitivity
[27], a finding also evident in the present study. However,
the present data show a reduction in plasma adiponectin in
response to endurance exercise training alongside a parallel
increase in insulin sensitivity. The literature on the effects of
exercise training on plasma adiponectin concentration is
inconclusive, with increases [14], decreases [16], and no
change [17] reported, although often this includes different
types of exercise or durations of training. Interestingly, we
observed no significant effect of exercise training on adipose
tissue expression of the adiponectin gene or its receptors.
Similar results were obtained after correcting for fat mass
(data not shown); therefore, the results cannot be explained
by a reduction in fat mass with exercise. However, the
adipocytes were obtained from a single fat depot; and it is
possible that the lower circulating adiponectin concentra-
tions post–exercise training could reflect a reduction in
adiponectin production by another depot, such as visceral fat,
or by a level of posttranscriptional or posttranslational
control. To understand how the expression of ADIPOQ
213C.N. Moran et al. / Metabolism Clinical and Experimental 60 (2011) 206–214relates to adiponectin production, it would have been
necessary to measure adiponectin protein in adipose tissue
biopsies by Western blotting.
The model for adiponectin explains almost half the
variance in ISI and predicts that increased fat mass is
correlated with reduced ISI, whereas, after correction for fat
mass, increased plasma adiponectin is an independent
predictor of, and correlated with, increased ISI. The influences
of ADIPOQ, ADIPOR1, and ADIPOR2 mRNAs are
dependent on subject group. Modeling of the change in ISI
against the change in the adiponectin “system” explained
22.8% of the variance inΔ ISI and identified subject group as
an important element likely because there were no significant
group by exercise interaction effects for the adiponectin
“system” that could match the significant interaction effect in
ISI. The model predicts that reducing plasma adiponectin will
reduce the control group's ISI, but increase the offspring
group's ISI, although an understanding of the change in fat
mass must also be factored in to this. Recent evidence
suggests that the ratio of high–molecular-weight adiponectin
to total adiponectin is more closely related to insulin
resistance than simply the total adiponectin, as measured in
the present study [28]. Furthermore, Schober et al [29] have
shown that different forms of adiponectin can have opposing
effects; high–molecular-weight adiponectin enhanced inter-
leukin-6 release from isolated monocytes, whereas low–
molecular-weight adiponectin reduced interleukin-6 release.
Thus, these apparently contradictory effects of adiponectin on
ISI may be the result of altered ratios of the forms of
adiponectin in the 2 groups. The model also indicates an
interaction between ADIPOR1 and ADIPOR2 mRNAs and
suggests that a balance between the 2 receptors is important
because they determine the pathway of adiponectin signaling.
Modeling of all variables at baseline explained 72.4% of the
variance in ISI, showing that the effects of the 2 “systems” are
at least partially independent. Importantly, it highlighted several
apparent points of interaction between the “systems” that
warrant further investigation: plasma adiponectin interacts
statistically with LEPRlong; ADIPOR1 mRNA interacts with
all the leptin variables, making it a crucial interaction point; and
ADIPOR2 mRNA interacts with leptin mRNA. This is
consistent with information in the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database, showing an interaction
between the 2 pathways in the activation of adenosine
monophosphate–activated protein kinase [3,30], and gives
information about the critical components to understand.
This work shows that, although both groups showed
beneficial changes with exercise, in fact improving cardiore-
spiratory fitness to a similar extent [13], at the molecular level,
exercise had differing effects in those with and without a
family history of diabetes. Changes in the leptin “system”were
more strongly related to exercise-induced changes in insulin
sensitivity than changes in the adiponectin “system,” although
the statistical models revealed points of communication
between the 2 “systems,” particularly at ADIPOR1. These
findings increase our understanding about how exerciseinfluences the expression of important metabolic genes in
subcutaneous adipose tissue and may help explain, at least in
part, why women with a family history of diabetes increase
insulin sensitivity to a greater extent than their peers with no
diabetes family history in response to exercise training.
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